| NCT ID | NCT07321314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | RSV |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2026-03-24 |
| Primary Completion | 2028-03-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2026-03-24 with a primary completion date of 2028-03-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
RSV infection causes significant mortality and morbidity in susceptible adults. There are many publications on the global RSV disease burden in infants and young children but data on adults are lacking with lots of knowledge gaps. Currently there is no established effective antiviral therapy for RSV. RSV vaccines have recently become available commercially but the Center for Health Protection (Hong Kong) has yet to discuss procurement of RSV vaccines for the high risk groups. Thus a prospective study to assess the disease burden of RSV infection in adults would be of great interest.
Eligibility Criteria
Inclusion Criteria: * Community-acquired respiratory tract infection symptoms * Age \>= 18 Exclusion Criteria: * Unable to provide a good quality of sputum and saliva
Contact & Investigator
David SC Hui, MD
STUDY DIRECTOR
Chinese University of Hong Kong
Frequently Asked Questions
Who can join the NCT07321314 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying RSV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07321314 currently recruiting?
Yes, NCT07321314 is actively recruiting participants. Contact the research team at chankapang@cuhk.edu.hk for enrollment information.
Where is the NCT07321314 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07321314 clinical trial?
NCT07321314 is sponsored by Chinese University of Hong Kong. The principal investigator is David SC Hui, MD at Chinese University of Hong Kong. The trial plans to enroll 10,000 participants.